Dario Scimeca - Feb 28, 2020 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: General Counsel and Secretary
Signature: /s/ Dario Scimeca
Stock symbol: DTIL
Transactions as of: Feb 28, 2020
Transactions value $: $52,659
Form type: 4
Date filed: 3/7/2022, 03:14 PM
Next filing: Jun 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Award	$11.6K	+2.07K		$5.61	2.07K	Feb 28, 2020	Direct
transaction	DTIL	Common Stock	Award	$15.1K	+3.16K	+152.32%	$4.79	5.23K	Aug 31, 2020	Direct
transaction	DTIL	Common Stock	Award	$12.7K	+2.75K	+52.56%	$4.61	7.98K	Feb 26, 2021	Direct
transaction	DTIL	Common Stock	Award	$5.85K	+548	+6.87%	$10.68	8.52K	Aug 31, 2021	Direct
transaction	DTIL	Common Stock	Award	$7.4K	+2.05K	+24.04%	$3.61	10.6K	Feb 28, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Employee Stock Option (Right to Buy)	Award	$0	+131K		$0.00	131K	Mar 3, 2022	Common Stock	131K	$4.08	Direct	F1
transaction	DTIL	Restricted Stock Units	Award	$0	+82.7K		$0.00	82.7K	Mar 3, 2022	Common Stock	82.7K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F2	The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3	The RSUs shall vest in three equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.